Patents by Inventor Stanford Peng

Stanford Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY
    Publication number: 20240075134
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: September 20, 2023
    Publication date: March 7, 2024
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20240075135
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: September 20, 2023
    Publication date: March 7, 2024
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20230201343
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: November 2, 2022
    Publication date: June 29, 2023
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY
    Publication number: 20230201344
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: November 9, 2022
    Publication date: June 29, 2023
    Inventors: Shyra Gardai, Che-Leung LAW, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY
    Publication number: 20220265822
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: May 2, 2022
    Publication date: August 25, 2022
    Inventors: Shyra Gardai, Che-Leung LAW, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20220249662
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 11, 2022
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley
  • METHODS AND USES OF VARIANT ICOS LIGAND (ICOSL) FUSION PROTEINS
    Publication number: 20220218785
    Abstract: Provided herein are immunomodulatory proteins comprising ICOSL variants and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
    Type: Application
    Filed: April 16, 2020
    Publication date: July 14, 2022
    Applicant: Alpine Immune Sciences, Inc.
    Inventors: Ryan SWANSON, Jing YANG, Stanford PENG, Jan HILLSON
  • Dosage and administration of non-fucosylated anti-CD40 antibodies
    Patent number: 11213584
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: January 4, 2022
    Assignee: Seagen Inc.
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • Dosage and administration of non-fucosylated anti-CD40 antibodies
    Patent number: 11202827
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: December 21, 2021
    Assignee: Seagen Inc.
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20170333556
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: October 29, 2015
    Publication date: November 23, 2017
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20170137528
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: January 20, 2017
    Publication date: May 18, 2017
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley